H. Yoshida et al., Effect of pituitary microsurgery on acromegaly complicated nephrotic syndrome with focal segmental glomerulosclerosis: Report of a rare clinical case, AM J KIDNEY, 33(6), 1999, pp. 1158-1163
A case of nephrotic syndrome complicated by acromegaly is presented. The fi
rst renal biopsy specimen showed minor glomerular abnormalities with glomer
ular hypertrophy, corresponding with minimal change nephrotic syndrome. Cor
ticosteroid therapy led to a partial remission, followed by frequent relaps
es after reduction of the drug. A diagnosis of atypical focal segmental glo
merulosclerosis (FSGS) was made based on the second renal biopsy results 6
months after the first. We combined steroid therapy with the administration
of an anticoagulant, cytotoxic agents, angiotensin-converting enzyme inhib
itor, and low density lipoprotein adsorption. Except for the angiotensin-co
nverting enzyme inhibitor, these medications were not effective in terms of
allowing a reduction in the high dosage of steroid, which in turn threaten
ed progressive osteoporosis and lumbar vertebrae fracture. Administering th
e steroid at a moderate dosage, treatment was focused on the complicating a
cromegaly from pituitary microadenoma. Subcutaneous injections of octreotid
e acetate, a somatostatin analogue, reduced proteinuria and increased urine
volume. Subsequent transsphenoidal microsurgery of the adenoma resulted in
the normalization of the elevated creatinine clearance and the further red
uction in steroid dosage while maintaining a remission state. This is the f
irst reported clinical case with acromegaly followed by FSGS, and it is sug
gested that hypersecretion of growth hormone participates in the developmen
t and progression of glomerular disease. (C) 1999 by the National Kidney Fo
undation, Inc.